DK0464101T3 - Forbedringer ved radioaktiv mærkning af proteiner - Google Patents

Forbedringer ved radioaktiv mærkning af proteiner

Info

Publication number
DK0464101T3
DK0464101T3 DK90905248.2T DK90905248T DK0464101T3 DK 0464101 T3 DK0464101 T3 DK 0464101T3 DK 90905248 T DK90905248 T DK 90905248T DK 0464101 T3 DK0464101 T3 DK 0464101T3
Authority
DK
Denmark
Prior art keywords
labelled
thiotriphosphates
antibody
proteins
tumour
Prior art date
Application number
DK90905248.2T
Other languages
English (en)
Inventor
Brian Maurice John Foxwell
Peter Parker
Andrew Malcolm Creighton
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of DK0464101T3 publication Critical patent/DK0464101T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Labeling Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90905248.2T 1989-03-23 1990-03-23 Forbedringer ved radioaktiv mærkning af proteiner DK0464101T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898906708A GB8906708D0 (en) 1989-03-23 1989-03-23 Improvements relating to the radiolabelling of proteins

Publications (1)

Publication Number Publication Date
DK0464101T3 true DK0464101T3 (da) 1994-12-19

Family

ID=10653894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905248.2T DK0464101T3 (da) 1989-03-23 1990-03-23 Forbedringer ved radioaktiv mærkning af proteiner

Country Status (8)

Country Link
EP (1) EP0464101B1 (da)
JP (1) JP2942776B2 (da)
AT (1) ATE114315T1 (da)
DE (1) DE69014300T2 (da)
DK (1) DK0464101T3 (da)
ES (1) ES2065525T3 (da)
GB (2) GB8906708D0 (da)
WO (1) WO1990011289A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583212A (en) * 1989-03-23 1996-12-10 British Technology Group Limited (gamma)-[32 p](gamma) -thioribonucleoside-51 -triphosphates
GB9103886D0 (en) * 1991-02-25 1991-04-10 Creighton Andrew 32p-thiophosphate preparation
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5728369A (en) * 1994-10-05 1998-03-17 Immunomedics, Inc. Radioactive phosphorus labeling of proteins for targeted radiotherapy
WO1996023816A1 (en) * 1995-02-01 1996-08-08 British Technology Group Limited Radiolabelled proteins
US6187286B1 (en) * 1996-12-27 2001-02-13 The General Hospital Corporation Tumor imaging agents, methods and kits

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
FR2585724B1 (fr) * 1985-08-01 1988-10-14 Centre Nat Rech Scient Kit de marquage enzymatique de nucleosides triphosphates et procede de preparation de nucleotides triphosphates marques au 32p ou 35s
GB2186579B (en) * 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins

Also Published As

Publication number Publication date
GB2248619B (en) 1993-02-24
GB9119528D0 (en) 1991-12-04
GB2248619A (en) 1992-04-15
EP0464101A1 (en) 1992-01-08
WO1990011289A1 (en) 1990-10-04
JP2942776B2 (ja) 1999-08-30
DE69014300T2 (de) 1995-04-13
EP0464101B1 (en) 1994-11-23
JPH04503809A (ja) 1992-07-09
DE69014300D1 (de) 1995-01-05
ATE114315T1 (de) 1994-12-15
ES2065525T3 (es) 1995-02-16
GB8906708D0 (en) 1989-05-10

Similar Documents

Publication Publication Date Title
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
FI100973B (fi) Menetelmä antigeenirakenteiden valmistamiseksi "Major Histocompatibili ty Complex" (MHC) luokka I -antigeeneistä ja monoklonaalisista vasta-a ineista
DE3575789D1 (de) Gleichseitige mehrfache proben und in denselben zu verwendende zusammensetzungen.
DK499086A (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
PT752876E (pt) Anticorpos monoclonicos que se conectam com o percursor antigeneo de rejeicao de tumores mage-1, mage-1 recombinante, e peptidos imunogenicos derivados de mage-1
DK121683D0 (da) Fremgangsmade til fremstilling af immunoenzymatiske konjugater
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
EP0415920A4 (en) Monoclonal antibody specific to hiv antigens
DK0853633T3 (da) Humant monoklonalt antistof imod hepatitis B virus overfladeantigen (HBVsAg)
KR880000585A (ko) 임파선증 결합 바이러스에 대한 인체 모노클로날항체
Carter et al. Isolation and partial characterization of “galactoprotein a”(LETS) and “galactoprotein b” from hamster embryo fibroblasts
DK0464101T3 (da) Forbedringer ved radioaktiv mærkning af proteiner
IT8719292A0 (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DE3887750T2 (de) Selektive entfernung von immunkomplexen.
ES8504928A1 (es) Procedimiento para la preparacion de un compuesto marcado con la acetilcolinestearasa de electrofurus electricus
ATE88901T1 (de) Fluorkohlenstoffkette enthaltende antigene konjugate.
Parkhouse Non-covalent association of IgM subunits produced by reduction and alkylation
NO168746C (no) Antistoff som er istand til aa binde histamin
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
JPS5531020A (en) Preparation of antiserum for coenzyme
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
SE7904276L (sv) Renat cancerassocierat protein
NO874798D0 (no) Fremgangsmaate for fremstilling av monoklonale antistoffer ved dyrking av hybridom-cellelinjen lym-1.